+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 70Years
All Genders
ID06723275

Validation Study of LEOPARD AI Models to Predict Mortality and Delisting in Liver Transplant Candidates with End-Stage Liver Disease or Liver Cancer

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-07-29

630

Participants Needed

8

Research Sites

39 weeks

Total Duration

AI-Summary

What This Trial Is About

This research focuses on developing and validating new artificial intelligence AI models to predict mortality or dropout risk among liver transplantation LT candidates. The study aims to improve the current MELD-based liver graft allocation systems, which have become less accurate over time, and to reduce disparities in waitlist outcomes across European countries. It is part of the LEOPARD European project funded by Horizon Europe, involving patients with decompensated cirrhosis, other end-stage liver diseases, or hepatocellular carcinoma HCC. Participants will undergo standardized assessments including tumor biopsies when applicable, and various biological samples such as blood, urine, ascites, and tumor tissue will be collected for biobanking and advanced biomarker analyses. The study includes three subsets of patients based on their liver disease diagnosis and is conducted across multiple European centers. These procedures aim to test current AI models and open pathways for future precision medicine approaches. During the study, participants will be closely monitored through clinical and laboratory evaluations to track outcomes such as mortality, dropout due to illness severity, transplantation timing, and post-transplant survival. The primary outcome is a composite measure of death or dropout due to being too sick within specific time frames after listing. Secondary outcomes include various mortality and recurrence rates, causes of dropout, and transplant benefits. The study duration extends up to 12 months post-listing or transplantation, allowing thorough follow-up and data collection.

CONDITIONS

Brief Title

LEOPARD Prospective Validation Cohort 1

Research Team

C

Christophe DUVOUX, MD-PHD

N

Nihel BERREBEH, Project Manager

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here